Belvedere Trading LLC Aurinia Pharmaceuticals Inc. Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$4.93 - $9.31 $11,541 - $21,794	2,341 Added 108.58%	4,497 $22,000
Q4 2023 Feb 13, 2024	SELL	$7.13 - $9.49 $969 - $1,290	-136 Reduced 5.93%	2,156 $19,000
Q3 2023 Oct 27, 2023	BUY	$7.77 - $12.27 $17,808 - $28,122	2,292 New	2,292 $17,000
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $33,976 - $64,464	5,720 Added 189.4%	8,740 $95,000
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $12,412 - $24,582	3,020 New	3,020 $13,000

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.04B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.